OBJECTIVES: Visceral malperfusion after coronary artery bypass grafting (CABG) results in high morbidity and mortality. This study was designed to evaluate the effect of CABG performed by surgical techniques on visceral perfusion and function.
INTRODUCTION
The incidence of gastrointestinal complications after coronary artery bypass grafting (CABG) occurs up to 4.1% [1] . Gastrointestinal bleeding, ileus, pancreatitis, liver failure and mesenteric ischaemia are the most dreaded of these complications with mortality rates of 10-90%. Gastrointestinal complications are a difficult clinical problem due to the non-specific nature of the symptoms and difficulty in diagnosis [1] . Furthermore, renal failure is a common problem after CABG in up to 3.9% of cases [2] .
The exact multifactorial and complex pathomechanism leading to visceral complications (VCs) are currently unknown, but perioperative visceral hypoperfusion has been suggested as the common aetiological factor in the development of VCs after CABG [1] .
Clinical risk factors for the development of VCs are hypovolemic shock, administration of α-adrenergic drugs, advanced age, re-thoracotomy, the use of an intra-aortic balloon pump, renal failure or prolonged extracorporeal circulation (ECC) time [1, 3] .
All these factors-alone or in combination-are more frequent in patients undergoing cardiac surgery compared with the general population [1, 3] . In addition, inflammatory response and reduction of visceral tissue blood flow during ECC has already been documented using Laser Doppler or microsphere techniques [4, 5] .
There is disparity between the effects of off-pump coronary artery bypass grafting (OPCAB) on reduction of the inflammatory response during CABG [6, 7] . Based on these findings, OPCAB surgery may be claimed to reduce VCs compared with conventional CABG.
There is conflicting evidence regarding the outcome in morbidity and mortality after CABG performed by OPCAB. One of the reasons for the inferior results after OPCAB in some studies could be haemodynamic instability induced by the cardiac positioning especially during lateral and posterior wall exposure [2] .
Haemodynamic stabilization during beating-heart myocardial revascularization by an intracardiac implanted blood pump has been achieved in experimental and clinical settings [8, 9] . The Impella elect 100 blood pump (Impella Cardiosystems, Aachen, Germany) has been developed to avoid haemodynamic instabilities while retracting the heart for exposure of lateral and posterior wall vessels or to allow prolonged stabilization.
Various surgical techniques are available nowadays; however, there are no data on visceral perfusion and organ function comparing the different techniques. Therefore, we decided to study the effects of ECC with cardioplegic arrest, OPCAB and microaxial blood pump supported beating-heart techniques on visceral blood flow, function and cellular damage in a porcine model.
MATERIALS AND METHODS
Twenty-eight domestic pigs with a body weight of 68-91 kg underwent experimental CABG procedures. The study was approved by the governmental Animal Care Committee.
All animals in this study received humane care in compliance with the 'Principles of Laboratory Animals' formulated by the National Society for Medical Research and the 'Guide for the Care and Use of Laboratory Animal Resource' published by the National Institutes of Health.
Animal preparation
The pigs were premedicated with ketamine (15 mg/kg), azaperone (3 mg/kg), atropine sulphate (0.5 mg) and midazolam (15 mg) injected intramuscularly. Anaesthesia was induced with sodium thiopental (2-3 mg/kg) and piritramide (15 mg) administered intravenously. The animals were intubated and pressure controlled ventilated with a peak pressure of 19-23 mbar, a positive end expiratory pressure of 3-5 mbar and a respiratory rate of 10-15 per minute with an FiO 2 of 0.3. Anaesthesia was maintained by continuous infusion of sodium-thiopental (2-3 mg/kg) and piritramide (7.5 mg/h). Additionally, during the 1-h intervention, 45 mg midazolam was infused continuously. Arterial blood gases were maintained within physiological ranges (ABL-System 615, Radiometer, Copenhagen, Denmark). Fluid replacement by full electrolyte solution (Sterofundin®, B. Braun, Melsungen, Germany) at a rate of 5-10 ml/kg/h was given. Intraoperative blood loss was replaced by hydroxethylstarch 6% (B. Braun).
Animal instrumentation
Catheters were introduced into both femoral arteries; a pulmonary artery catheter (Edwards Lifesciences, Unterschleissheim, Germany) was inserted via a femoral vein access for cardiac output (CCO) monitoring. After a median laparotomy, a urinary catheter was inserted. Then, a sternotomy was performed and the left internal mammary artery (IMA) was dissected. The pericardium was open vertically and a catheter was inserted in the left atrium for application of microspheres.
Study protocol
The 28 pigs were randomized into four groups (n = 7): I. Sham: a group without bypass surgery (sham operation) served as a control group; II. OPCAB: stabilizer for 1 h with 40 min intracoronary shunt; III. ECC: normothermic non-pulsatile ECC for 1 h with 40 min aortic cross-clamping and cardioplegic arrest; IV. Impella: beating-heart procedure assisted by the Impella® elect 100 microaxial blood pump for 1 h with 40 min intracoronary shunt. The surgical intervention lasted 60 min followed by 240 min of observation. CABG was performed during the first 40 min of intervention as left IMA to the left anterior descending coronary artery (LAD) bypass. Graft patency was confirmed by a CM 1005 transit time flowmetre with a 3-mm probe (Cardio Med GmbH, Taufkirchen Germany). The probe was placed 15-25 mm proximal to the anastomosis [8] . All constructed anastomoses were patent throughout the experiment. All animals received Heparin 500 units/kg prior to the intervention and an equivalent dose of protamine after the procedure. The activated clotting time was measured 2 min after heparin administration, at 25 and 50 min intervention. In all animals, every activated clotting time was prolonged more than 500 s, so no heparin had to be readministred. Normothermia was maintained in all groups by a heating blanket throughout the experiment.
Intervention set-up
In Groups II and IV, the IMA-to-LAD bypass was performed on the beating heart utilizing a stabilizer (Octopus Medtronic, MN, USA) and an intracoronary shunt (Guidant Axius Coronary Shunt, Guidant Corporation, Santa Clara, CA, USA). The completed bypass was occluded until the 40th min [8] .
In Group III, the circuit was primed with 500 ml full electrolyte solution (Sterofundin, B. Braun), 500 ml hydroxethylstarch 6% (B. Braun) and 250 ml mannitol 10% (Serumwerk Bernburg, Bernburg, Germany). The coronary artery bypass was accomplished during 40 min of aortic cross-clamping and cardioplegic arrest induced by St. Thomas solution (4-8°C, 10-15 ml/kg body weight) via the aortic root in a total of 60 min of ECC. Cardioplegia (7 ml/kg body weight) was readministered after 20-25 min of aortic crossclamping. The arterial cannula ( Jostra, Hirrlingen, Germany) was inserted into the ascending aorta. A venous catheter ( Jostra) was placed in the right atrium. A roller pump (Stöckert, Munich, Germany), a membrane oxygenator (Quadrox; Jostra) and a sterile tubing set containing a 40-µm arterial filter were used. The pump flow was adjusted to maintain mean arterial pressure between 55 and 80 mmHg to avoid vasopressor medication during ECC [8] .
Normothermia was maintained throughout the experiment. In Group IV, a microaxial blood pump (Impella elect 100, Impella Cardiosystems) was inserted in the left ventricle via the ascending aorta through a purse-string suture. About 500 ml of hydroxethylstarch 6% (B. Braun) was infused immediately before pump insertion. The correct position was checked by measuring the difference between aortic and left ventricular diastolic pressure. Rotational speed was adjusted so maximum ventricular unloading was achieved. Pump flow ranged from 1.9 to 3.5 l/min. The Impella pump was operated for 60 min. The surgical procedure was identical to that of Group II.
Measurements
Mean arterial blood pressure (MAP, mmHg), central venous pressure (mmHg) and left atrial pressure (mmHg) were measured continuously. CCO (l/min) was measured by the continuous thermodilution method (CCOmbo, Edwards Lifesciences, Unterschleissheim, Germany).
Arterial and venous blood samples were taken at defined time points: baseline, during the surgical procedure (40 and 50 min) and 10 min (70 min), 1 (120 min) and 4 h (300 min) after bypass. Urine samples were collected at baseline, 1 (120 min) and 4 h (300 min) after bypass.
Visceral perfusion measurement
Regional visceral blood flow was examined at baseline, twice during the surgical procedure (40 and 60 min) and 1 (120 min) and 4 h (300 min) after bypass by fluorescence-labelled microspheres (Molecular probes, Leiden, Netherlands) [10] . Two million microspheres per colour were injected into the left atrium over 30 s via the left atrial catheter. During ECC, the microspheres were injected in the arterial cannula. A 10-ml reference blood sample was withdrawn from the abdominal aorta with a syringe pump (Model 540210, TSE, Bad Homburg, Germany) over a 3-min period starting 30 s before the microsphere injection. At the end of the observation, 51 specimens weighing 500-1500 mg were dissected from the visceral organs (liver n = 8, kidneys n = 20, pancreas n = 9, small bowl n = 8, colon n = 4, rectum n = 2). For digestion and dye extraction, we used a previously published protocol [10] .
Clinical chemistry analysis
Arterial blood samples (4 ml) were drawn from the femoral arterial catheter to determine plasma creatinine (Roche Diagnostics, Mannheim, Germany), intestinal fatty acid binding protein (iFABP) (Hycult biotechnology, Uden, Netherlands), lipase and amylase concentrations and liver enzymes concentrations (α-glutathione stransferase [Biotrin, Heidelberg, Germany], glutamate-oxaloacetate transaminase (GOT), gamma-glutamyl transferase (GGT), glutamate dehydrogenase and glutamate-pyruvate transaminase (GPT); Roche Diagnostics).
Renal excretory function was measured by determination of creatinine clearance (CC). Therefore, plasma and urine creatinine concentrations were determined at baseline, 1 and 4 h after surgery. Urine was collected over a period of 1 h. CC was calculated using the formula: CC ¼ urine volume Â urine creatinine=plasma creatinine CC=BSA ðml/min m 2 Þ
Statistics
All data are presented as mean ± standard deviation. Data analysis was performed using SigmaStat 3.1 ( Jandel Scientific Corp., San Rafael, CA, USA). The statistical significance of changes from baseline within each group was tested with analysis of variance (ANOVA) for repeated measurements and post hoc analysis. Differences between the groups were analysed by one-way ANOVA, followed by post hoc analysis including the correction of an alpha error according to Bonferroni to compensate for multiple comparisons. If values did not show normal distribution, ANOVA for nonparametric values (Kruskal-Wallis test) was used with the multiple comparison method (Dunn or Bonferroni method). Statistical significance was accepted at an error probability of P ≤ 0.05 after pairwise testing.
RESULTS

Haemodynamic parameters and fluid balance
The fluid balance for the entire experimental duration did not differ significantly among the groups (Sham 2401 ± 1162 ml; OPCAB: 2950 ± 1252 ml; ECC: 2430 ± 1747ml; Impella: 2499 ± 1374 ml).
In Group I (Sham), haemodynamics remained constant throughout the experiment (Fig. 1, Table 1 ). The OPCAB procedure (Group II) was associated with a significant decrease in CCO compared with Group III (ECC) (P = 0.009) and corresponding alterations of MAP compared with baseline (P = 0.02) and Sham (P = 0.008).
In Group III, the onset of ECC initiated a significant decrease in MAP which remained below baseline (P < 0.001) and Sham (P < 0.001).
In Group IV (Impella), CCO and MAP were also significantly reduced during CABG compared with baseline (P = 0.04; P = 0.01) and Sham (P = 0.03; P = 0.04; Fig. 1 ). Conversely, during surgery, MAP (P < 0.001) and CCO (P = 0.03) were significantly higher in Group IV than in the Group III. During reperfusion, MAP was significantly decreased in Groups II and III compared with baseline (P = 0.001; P < 0.001) and Sham (P = 0.01; P = 0.02).
Visceral perfusion measurements
In all ECC animals, microsphere injection through the aortic cannula resulted in homogenous mixing as indicated by a similar fluorescence (<5% difference between the pairwise measurements) both in bilateral kidney samples and in both reference blood samples drawn simultaneously. No significant changes in hepatic, splenic and rectal blood flow were observed in any groups (Table 2) .
In Group I, microvascular perfusion in all visceral specimens remained constant throughout the experiment (Figs 2-5, Table 2 ).
In Group II, a significant decrease in pancreatic (P = 0.03) and small bowel muscularis blood (P = 0.03) flow during bypass surgery was observed.
In Group III, the onset of ECC initiated a significant decrease in pancreatic (P = 0.001), renal (P = 0.002), small bowel (P = 0.01) and large bowel blood flow (P = 0.04). Renal (P = 0.004) and small bowel (P = 0.01) blood flow were significantly reduced during ECC compared with OPCAB. During reperfusion, renal blood flow remained below baseline (P = 0.002) and Sham (P = 0.01).
In Group IV, pancreatic (P = 0.003), renal (P = 0.002), small bowel (0.02) and large bowel (0.007) blood flow were significantly decreased during Impella support. After discontinuing the Impella, renal medullary blood flow remained below baseline (P = 0.03) and Sham (P = 0.009) (Fig. 3B) , whereas small bowel muscularis and large bowel muscularis blood flow slowly returned to baseline over 240 min (Figs 4B and 5B).
Blood analysis
In the Sham, OPCAB and Impella groups, haematocrit remained constant. In Group II, a significantly reduced haematocrit (P = 0.003) during ECC was observed (Table 1 ). In the Sham and OPCAB groups, iFABP, pancreatic enzyme levels and CC remained constant throughout the experiment (Fig. 6, Table 1 ). The liver enzyme alpha-glutathione S-transferase was comparable between all groups. GOT level increased significantly during the reperfusion in Groups II-IV compared with baseline (P = 0.003; P < 0.001; P = 0.004). In Group III, the onset of ECC initiated a significant increase in the iFABP level compared with baseline (P < 0.001), Sham (P < 0.001) and OPCAB (P = 0.002). The plasma concentrations of GPT (P < 0.001), GGT (P < 0.001), lipase (P = 0.009) and amylase (P = 0.003) were significantly reduced during ECC compared with baseline, Sham, OPCAB and Impella. During reperfusion, urine creatinine (P = 0.003) and CC (P = 0.01) significantly decreased, whereas urine output significantly increased compared with baseline (P = 0.04) and Sham (P = 0.005).
In Group IV, a significant increase in the iFABP level was found during Impella support (P = 0.02), which remained elevated, compared with baseline (P = 0.002) and Sham (P < 0.001) until the end of the experiment. Pancreatic enzymes and CC levels remained constant throughout the experiment.
DISCUSSION
CABG with ECC leads to a systemic inflammatory response syndrome (SIRS) with haemodynamic changes most commonly involving vasodilatation and the need for vasopressor treatment [1] . Systemic vasodilatation is a frequent haemodynamic finding of SIRS induced by ECC [1] . Hypotension despite adequate pump flow is felt to be a contributing factor to organ ischaemia [11] . Several studies have documented changes in visceral microcirculation during ECC [4, 5] .
In order to understand the pathological mechanism of VCs, it is necessary to study the physiological response of the visceral perfusion to CABG performed by different surgical techniques. In this study, global haemodynamics and visceral microcirculation were analysed, since microcirculation may not follow the regulation of global blood flow [5] . Furthermore, we particularly focused on functional visceral organ damage, like CC, liver and pancreatic enzyme release and iFABP plasma concentration, which is a specific marker of intestinal cell damage [12] . As controls, we chose a group of animals without bypass surgery, but exposed to all other surgical manipulations. During ECC, we maintained pump flow at the level of baseline CCO. Blood flow in the liver, spleen and rectum were not significantly affected by ECC in our experiments. Pancreatic, renal and intestinal blood flow, however, showed a pathological response in line with previous studies [4, 5] . The impairment of pancreatic, renal and intestinal perfusion was also confirmed by pancreatic enzyme release, decreased CC and increased iFABP plasma concentration. The changes in renal blood flow persisted until the end of the experiment. These observations indicate a significant impairment of pancreatic, renal, small and large bowel blood flow induced by ECC with cardioplegic arrest. The compromised blood flow in these visceral organs led to a cellular damage indicated by the release of the respective organ-specific enzymes.
Interestingly, despite a significant decrease in CCO during off-pump surgery, visceral blood flow remained normal. Only pancreatic blood flow was decreased during OPCAB. However, no increased pancreatic enzyme level was detected. Thus, the reduction in macroscopic blood flow probably did not have a measureable adverse effect on pancreatic tissue blood flow and function. We conclude that OPCAB in our model leads to preserved visceral blood flow and may maintain cellular integrity.
A significant increase in iFABP plasma concentration, which is a specific marker of intestinal cell damage, was found in the Impella and ECC groups. Increased iFABP plasma concentration has also been described in previous mesenteric ischaemia studies [12] . We are able to demonstrate that the observed impairment in intestinal perfusion results in an intestinal cellular damage, whereas all clinically measured parameters indicate a safe extracorporeal perfusion. Thus, in our model of a clinically uncomplicated surgical myocardial revascularization utilizing ECC, we showed intestinal damage.
Microaxial blood pump support during beating-heart CABG leads to visceral cell destruction, although systemic haemodynamic parameters (CCO and mean arterial pressure) are enhanced compared with the OPCAB procedure. In contrast to the optimized systemic haemodynamic state, an impaired regional visceral blood flow was found. In a previous study, we could demonstrate a strong correlation between embolic load and cerebral oedema caused by impaired cerebral perfusion [7] . The source of these emboli resulted from gaseous bubbles formed by cavitation processes [7] . Since the current instrumentation is similar to the set-up of the previously conducted experiments, we conclude that microaxial blood pump support causes regional visceral malperfusion by emboli formation.
This significantly reduced emboli count in the OPCAB group compared with the ECC group may in part also explain the observed improved visceral perfusion in the current study [7] . Additionally, we found a statistically less pronounced blood pressure reduction in the OPCAB group compared with the ECC group. In the OPCAB group, the MAP during the surgical procedure, although significantly reduced to its baseline, was still in a range considered clinically safe. In contrast, in the ECC group, the MAP fell in a range that has been associated with a worse clinical outcome. Clinical studies defining this unsafe blood pressure range as hypotension revealed adverse outcomes (increased mortality, stroke and renal failure) in hypotensive patients during CABG utilizing ECC [13, 14] . Furthermore, we observed a significantly decreased haematocrit due to haemodilution in the ECC group compared with its baseline and the OPCAB group. Marked haemodilution, as seen in the ECC group in our experiment, is associated with increased mortality and risk of postoperative organ dysfunction including stroke, low cardiac output, acute renal failure and multiorgan dysfunction [15] . Additionally, the lack of pulsatility during non-pulsatile ECC is claimed to contribute to visceral organ dysfunction. However, in some studies, no beneficial effect on renal [16] and splanchnic organ function [17] was observed, whereas, in other studies, a protective effect of pulsatile ECC on renal [18] and splanchnic organ function [19] was identified. Moreover, an exact definition of pulsatile blood flow during ECC has not been established, so there is no comparability among these clinical studies [20] . Therefore, the available data in adults are difficult to interpret, and hence, it is too speculative to attribute a beneficial effect of pulsatility during ECC on improved visceral organ blood flow and function.
These findings indicate that the ECC and the left ventricular placed microaxial blood pump induce visceral microcirculatory alterations which may lead to VCs after CABG.
The use of off-pump strategies in current clinical practice has been considered safe [21] . There is conflicting evidence concerning long-term outcomes. In regard to visceral perfusion, no data have been reported yet. Clinically, VCs after CABG occur in 1.49% of conventional and in 0.91% of OPCAB patients, although these findings did not differ significantly [22] . In our experiment, the off-pump procedure did not alter the iFABP level. In addition, off-pump surgery resulted in a preserved intestinal blood flow and function.
Our results in the OPCAB group-with normal iFABP level being associated with normal visceral blood flow and function-are in line with previous findings of a protective effect of off-pump surgery in regard to VCs after CABG [2, 3, 9] . The incidence of mesenteric ischaemia and renal failure has been reduced by OPCAB especially in high-risk patients [2, 23] .
However, the benefits of OPCAB surgery are controversially discussed since recent trials such as the CORONARY and the GOPCABE trials showed no survival benefit in comparison with on-pump surgery. Nevertheless, this is more likely related to the higher rates of major adverse cardiac events, namely driven by repeated target revascularizations with associated myocardial ischaemia. Apart from this phenomenon, patients with generalized atherosclerotic disease may benefit from the less impaired visceral perfusion lowering the risk of visceral ischaemia in the perioperative course of coronary artery bypass surgery [24, 25] .
In conclusion, in this porcine model, ECC and microaxial blood pump support lead to visceral cell injury caused by decreased regional blood flow. Off-pump CABG appears to maintain adequate visceral blood flow and function.
LIMITATIONS
The observations were made in previously healthy animals with normal organs without any evidence of atherosclerosis. Thus, our results should be carefully interpreted.
